Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Matthias Schmitt-Haendle"'
Autor:
Marlene Stephan, Koray Tascilar, Melek Yalcin-Mutlu, Melanie Hagen, Judith Haschka, Michaela Reiser, Fabian Hartmann, Arnd Kleyer, Axel J. Hueber, Bernhard Manger, Camille Figueiredo, Jayme Fogagnolo Cobra, Hans-Peter Tony, Stephanie Finzel, Stefan Kleinert, Jörg Wendler, Florian Schuch, Monika Ronneberger, Martin Feuchtenberger, Martin Fleck, Karin Manger, Wolfgang Ochs, Matthias Schmitt-Haendle, Hannes Martin Lorenz, Hubert Nüsslein, Rieke Alten, Joerg Henes, Klaus Krüger, Georg Schett, Jürgen Rech
Several studies have shown that tapering or stopping disease-modifying anti-rheumatic drugs (DMARDs) in rheumatoid arthritis (RA) patients in sustained remission is feasible. However, tapering/stopping bears the risk of decline in physical function a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e79a7c7396a3c8c2f2c628d5b58eb29b
https://opus4.kobv.de/opus4-fau/files/23291/jcm-12-03723.pdf
https://opus4.kobv.de/opus4-fau/files/23291/jcm-12-03723.pdf
Autor:
Thomas Harrer, Michael Bäuerle, Sandra M. Mueller, Barbara Schmidt, Klaus Korn, Birgit Schaetz, Heinrich Sticht, Hauke Walter, Bernd M. Spriewald, Kathrin Eismann, Matthias Schmitt-Haendle, Silke Bergmann, Ellen G. Harrer
Publikováno v:
Journal of Virology. 81:2887-2898
To determine the influence of human immunodeficiency virus type 1 (HIV-1)-specific CD8+T cells on the development of drug resistance mutations in the HIV-1 protease, we analyzed protease sequences from viruses from a human leukocyte antigen class I (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f662eabe010a45fb670fa3ccc8525e5
https://doi.org/10.1128/jvi.01547-06
https://doi.org/10.1128/jvi.01547-06
Autor:
Matthias Schmitt-Haendle, Katja Maurer, Ellen G. Harrer, Silke Bergmann, Sandra M. Mueller, Bernd M. Spriewald, Kathrin Eismann, Thomas Harrer, Andreas Goldwich
Publikováno v:
Journal of acquired immune deficiency syndromes (1999). 48(2)
Objectives: To study the role of cytotoxic T-lymphocyte (CTL) escape for disease progression in HIV-1 infection, we analyzed the CTL response to the dominant human leukocyte antigen (HLA)-B8-restricted CTL epitope FLKEKGGL (FL8) in HIV-1 Nef. Methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c30de0ebb7882a292ca20b64586bd392
https://pubmed.ncbi.nlm.nih.gov/18391752
https://pubmed.ncbi.nlm.nih.gov/18391752
Autor:
Barbara Schmidt, Matthias Schmitt-Haendle, Michael Bäuerle, Ellen G. Harrer, Thomas Harrer, Oliver Bachmann
Publikováno v:
Viral immunology. 18(4)
The cytotoxic T-lymphocytes (CTL) response to three histocompatibility leukocyte antigen (HLA)-A2-restricted CTL epitopes was investigated in a cohort of 51 HLA-A2-positive human immunodeficiency-1 (HIV-1)-infected subjects. CTL activity was evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c0c39032f9e15fee18df52e9c129c0
https://pubmed.ncbi.nlm.nih.gov/16359229
https://pubmed.ncbi.nlm.nih.gov/16359229
Autor:
Matthias Schmitt-Haendle, Oliver Bachmann, Ellen Harrer, Barbara Schmidt, Michael Bäuerle, Thomas Harrer
Publikováno v:
Viral Immunology; Winter2005, Vol. 18 Issue 4, p627-636, 10p
Autor:
Karin J. Metzner, Verena Kubesch, Gerold Schuler, Jan Dörrie, Christian Hofmann, Niels Schaft, Thomas Harrer, Katja Maurer, Matthias Schmitt-Haendle, Silke Bergmann, Kathrin Eismann
Publikováno v:
ResearcherID
Background HIV-1-specific cytotoxic T lymphocytes, which recognize conserved epitopes of the virus, are correlated with prolonged survival of infected individuals. Unfortunately, most HIV-1-infected patients are unable to generate such an immune resp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ddd0c9cc83deee00d8ea7e3ad2e6c7d
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000258761600006&KeyUID=WOS:000258761600006
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000258761600006&KeyUID=WOS:000258761600006